Ventura MT, Polimeno L, Amoruso AC, Gatti F, Annoscia E, Marinaro M, Di Leo E, Matino MG, Buquicchio R, Bonini S, Tursi A, Francavilla A
How many rounds?" So I just wanted to know more about the safety perspective of this
Compared with other CVOTs involving GLP-1RA, participants in the AMPLITUDE-O trial had the longest duration of diabetes (15 years), lowest mean eGFR (72 ml/min/1.73 m 2 ) with a higher percentage (32%) of people with renal disease (eGFR 2560 mL/min), highest glycosilated hemoglobin (8.9%), and highest percentage of insulin use (62%) or sodiumglucose transporter-2 inhibitors (SGLT-2i) (15%) at baseline, thus identifying a more fragile population
Quicker Start for New Users Many people find nasal spray less intimidating, making it easier to begin using Melanotan 2 without extensive preparation or experience
In 2025 we saw label expansions for semaglutide and tirzepatide, underscoring a trend toward whole-body health
K.VerrierP
